Ajay, K., Deepa, I., Purnima, A. and Neeraj, V. 2009. Silymarin: a comprehensive review. Pharmacognosy Reviews, 3(5): 116–124.

Alarcon de la Lastra, C., Martin, M.J. and Marhuenda, E. 1992. Gastric antiulcer activity of silymarin, a lipoxygenase inhibitor in rats. Journal of Pharmacology, 44: 929–931. https://doi.org/10.1111/j.2042-7158.1992.tb05464.x

Auroux, J., Lamarque, D., Roudot-Thoraval, F., Deforges, L., Chaumette, M.T., Richardet, J.P. and Delchier, J.C. 2003. Gastroduodenal ulcer and erosions are related to portal hypertensive gastropathy and recent alcohol intake in cirrhotic patients. Digestive Diseases and Sciences, 48(6): 1118–1123. https://doi.org/10.1023/A:1023735706020

Bexfield, N. and Watson, P. 2009. Treatment of canine liver disease: managing clinical signs and specific liver diseases. In Practice, 31: 172–180.

Bolton, J.P. 1985. Tests related to the stomach. In: Berk, J.E. et al., (Eds.), Bockus Gastroenterology, 4th edn., Vol. 1. WB Saunders, Philadelphia, pp. 367–377.

Bosch, J., Berzigotti, A., Garcia-Pagan, J.C. and Abraldes, J.G. 2008. The management of portal hypertension: rational basis and available treatments. Journal of Hepatology, 48(Suppl.1): S68–S92. https://doi.org/10.1016/j.jhep.2008.01.021

Bunch, S.E., Rothuizen, J. and Charles, J.A. 2006. WSAVA Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Disease. Saunders/Elsevier, UK.

Buob, S., Johnston, A.N. and Webster, C.R.L. 2011. Portal hypertension: pathophysiology, diagnosis and treatment. Journal of Veterinary Internal Medicine, 25(2): 169–186. https://doi.org/10.1111/j.1939-1676.2011.0662.x

Calvert, C.A. and Thrall, D.E. 1982. Treatment of canine heartworm disease with right-sided heart failure. Journal of the American Veterinary Medical Association, 180: 1201–1203.

Chandrasekar, M., Nambi, A.P., Ramprabhu, R. and Dhanapalan, P. 2002. Epizootiological studies on canine ehrlichiosis. Indian Veterinary Journal.

Chaudhuri, S., Varshney, J.P. and Patra, R.C. 2008. Erythrocytic antioxidant defense in dogs infected with Babesia gibsoni. Research in Veterinary Science, 85(1): 120–124. https://doi.org/10.1016/j.rvsc.2007.10.008

Choi, M.A., Kim, B.S. and Yu, R. 1999. Serum antioxidative vitamin levels in gastric carcinoma patients. Cancer Letters, 136: 89–93. https://doi.org/10.1016/S0304-3835(98)00322-4

Crnogaj, M., Petlevski, R., Mrljak, V. et al., 2010. Malondialdehyde levels in dogs infected with Babesia canis. Veterinarni Medicina, 55(4): 163–171. https://doi.org/10.17221/299/2009-VETMED

Day, M.J., Bilzer, T. and Mansell, J. 2008. Histopathological standards for diagnosis of gastrointestinal inflammation. Journal of Comparative Pathology, 138: S1–S43. https://doi.org/10.1016/j.jcpa.2007.11.001

Dixon, M.F., Genta, R.M., Yardley, J.H. and Correa, P. 1996. Classification and grading of gastritis. American Journal of Surgical Pathology, 20: 1161–1181. https://doi.org/10.1097/00000478-199610000-00001

Doige, C.E. and Furneaux, R.W. 1975. Liver disease and intrahepatic portal hypertension in dogs. Canadian Veterinary Journal, 16(7): 209–214.

Dowdle, S.M., Joubert, K.E., Lambrechts, N.E. et al., 2003. Subclinical gastroduodenal ulceration in dachshunds. Journal of the South African Veterinary Association, 74(3): 77–81. https://doi.org/10.4102/jsava.v74i3.507

Drake, I.M., Mapstone, N.P., Schorah, C.J. et al., 1998. Reactive oxygen species activity in Helicobacter pylori gastritis. Gut, 42: 768–771. https://doi.org/10.1136/gut.42.6.768